Skip to content

Mark Takai to Undergo Treatment for Pancreatic Tumor

Takai will undergo treatment for the tumor. (Tom Williams/CQ Roll Call File Photo)
Takai will undergo treatment for the tumor. (Tom Williams/CQ Roll Call File Photo)

Freshman Rep. Mark Takai, D-Hawaii, has been diagnosed with a small tumor on his pancreas after undergoing tests to determine the source of stomach pain.  

Takai, 48, released a statement about the health issue after it caused him to miss House votes on Monday and Tuesday. “A few days ago, my doctors conducted diagnostic tests in response to certain stomach pains and discomfort that I have been experiencing for several weeks. The tests show that I have a small tumor in the pancreas and I will shortly begin treatment. My prognosis is very good thanks to early detection and my doctors are confident that I will make a speedy and full recovery,” Takai said in the release dated Oct. 27.  

“I do not expect to be away from my duties for more than a brief period and look forward to quickly returning to serving the needs of my constituents in Hawaii,” he added.  

Takai served in the Iraq War before joining Congress. He is also a lieutenant colonel in the Hawaii Army National Guard. Colleagues, including Rep. Debbie Wasserman Schultz, D-Fla., said they would be pulling for the “fighter” in his recovery.  

“My wife Sami and our entire family are grateful for your prayers and support,” Takai stated. “We ask for continued respect of our family’s privacy as we move forward with treatment.”


See photos, follies, HOH Hits and Misses and more at Roll Call’s new video site.


Get breaking news alerts and more from Roll Call in your inbox or on your iPhone.

Recent Stories

After loss in mayor’s race, Jackson Lee faces decision

High-speed routes biggest winners in latest rail funding round

Appeals court upholds most of Trump gag order in DC case

Kevin Up — Congressional Hits and Misses

House GOP cites new Hunter Biden charges in impeachment push

Congress must protect our servicemembers by reauthorizing Section 702